داروسازی کاسپین تامین
کاسپین | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 35,240 2.97
Close Price: 35,240
Balance Sheet
AGM
Interim
2026/07/08 Fiscal Year 2026/03/2012 Month | 2025/05/17 Fiscal Year 2025/03/2012 Month | 2024/05/15 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 4.604 Trillion | 1.887 Trillion | 896.538 Billion | |
Short-Term Investments | 61.977 Billion | 67.55 Billion | 40.619 Billion | |
Trade Receivables | 34.946 Trillion | 16.73 Trillion | 9.441 Trillion | |
Prepayments | 3.215 Trillion | 1.918 Trillion | 1.11 Trillion | |
Raw Materials & Packaging Inventory | 5.985 Trillion | 3.433 Trillion | 2.782 Trillion | |
Work-in-Progress Inventory | 1.522 Trillion | 1.267 Trillion | 769.348 Billion | |
Finished Goods Inventory | 1.854 Trillion | 770.407 Billion | 398.394 Billion | |
Spare Parts Inventory | 489.033 Billion | 269.791 Billion | 110.43 Billion | |
Goods in Transit | 512.54 Billion | 421.322 Billion | 251.285 Billion | |
Our Goods on Consignment with Others | 6.78 Billion | 6.678 Billion | 6.539 Billion | |
Inventories | 10.35 Trillion | 6.153 Trillion | 4.299 Trillion | |
Total Current Assets | 53.193 Trillion | 26.772 Trillion | 15.803 Trillion | |
Intangible Assets | 161.799 Billion | 161.679 Billion | 164.884 Billion | |
Other Assets | 596 Million | 596 Million | 480 Million | |
Property, Plant & Equipment | 8.391 Trillion | 8.074 Trillion | 2.598 Trillion | |
Net Fixed Assets | 8.391 Trillion | 8.074 Trillion | 2.598 Trillion | |
Total Non-Current Assets | 8.554 Trillion | 8.237 Trillion | 2.764 Trillion | |
Total Assets | 61.747 Trillion | 35.008 Trillion | 18.567 Trillion | |
Trade Payables | 2.375 Trillion | 1.709 Trillion | 3.418 Trillion | |
Advances Received | 281.134 Billion | 12.312 Billion | 16.611 Billion | |
Income Tax Provision | 5.979 Trillion | 2.22 Trillion | 1.517 Trillion | |
Other Provisions | 475.689 Billion | 521.737 Billion | 471.259 Billion | |
Proposed & Payable Dividends | 5.975 Trillion | 2.1 Trillion | 110.488 Billion | |
Current Borrowings | 11.423 Trillion | 8.6 Trillion | 6.247 Trillion | |
Total Current Liabilities | 26.508 Trillion | 15.163 Trillion | 11.781 Trillion | |
Long-Term Borrowings | 2.88 Trillion | 1.482 Trillion | 163.396 Billion | |
Employee Termination Benefits Provision | 536.628 Billion | 369.791 Billion | 256.658 Billion | |
Total Non-Current Liabilities | 3.417 Trillion | 1.852 Trillion | 420.054 Billion | |
Total Liabilities | 29.925 Trillion | 17.014 Trillion | 12.201 Trillion | |
Capital | 7.94 Trillion | 1.4 Trillion | 1.4 Trillion | |
Retained Earnings | 23.127 Trillion | 11.449 Trillion | 4.886 Trillion | |
Legal Reserve | 794 Billion | 140 Billion | 140 Billion | |
Expansion & Development Reserve | 6.937 Billion | - | - | |
Share Premium Reserve | -46.299 Billion | -40.726 Billion | -67.397 Billion | |
Other Reserves | - | 6.937 Billion | 6.937 Billion | |
Total Equity | 31.821 Trillion | 17.994 Trillion | 6.366 Trillion | |
Total Liabilities & Equity | 61.747 Trillion | 35.008 Trillion | 18.567 Trillion | |
Approved Capital | 7.94 Trillion | 1.4 Trillion | 1.4 Trillion | |
Approved Retained Earnings | 7.803 Trillion | 3.469 Trillion | 1.666 Trillion | |
Approved Legal Reserve | 794 Billion | 140 Billion | 140 Billion | |
Approved Expansion & Development Reserve | 6.937 Billion | - | - | |
Other Approved Reserves | - | 6.937 Billion | 6.937 Billion | |
Total Approved Equity (at AGM) | 16.544 Trillion | 5.016 Trillion | 3.213 Trillion | |
Non-Current Assets Held for Sale | 16.1 Billion | 16.1 Billion | 16.1 Billion | |
کالای امانی دیگران نزد ما | 18.563 Billion | 15.967 Billion | 18.513 Billion | |
Revaluation Surplus of Property, Plant and Equipment | - | 5.038 Trillion | - |